MedPath

Entacapone

Rx Only

Approved
Approval ID

56327e32-3b06-4144-91a0-bb1908842e33

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 18, 2023

Manufacturers
FDA

Macleods Pharmaceuticals Limited

DUNS: 862128535

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Entacapone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33342-260
Application NumberANDA207210
Product Classification
M
Marketing Category
C73584
G
Generic Name
Entacapone
Product Specifications
Route of AdministrationORAL
Effective DateDecember 25, 2023
FDA Product Classification

INGREDIENTS (12)

ENTACAPONEActive
Quantity: 200 mg in 1 1
Code: 4975G9NM6T
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.